2G7-31228-96017
3 vaccinations
9 coded responses
30 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 038 / NH
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Dose 1 — Moderna
-
2021-01-20
Registered in v-safe
-
2021-01-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Good · Site: Pain, RednessFree text: LightheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-18
Dose 2 — Moderna
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-06
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Survey response — day 42, dose 2MedDRA: Derealisation, Dissociation, Office visit — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Dissociation/derealization · Healthcare visit (other): In office visit with psych and PCPMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
- 2021-06-08
-
2021-08-22
Survey response — 6 months, dose 2MedDRA: Autonomic nervous system imbalance — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Autonomic dysfunctionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-24
-
2021-11-30
Dose 3 — Moderna
-
2021-12-01
Survey response — days 1–6 daily, dose 3MedDRA: Brain fog, Discomfort, Ear discomfort, Head discomfort, Rash macular, Skin discolouration, Somnolence — Feeling: Poor · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Groggy/brain fog, ear fullness, head & facial pressure, EXTREMELY red & splotchy/discolored hands & feetMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-12-04
- 2021-12-05
- 2021-12-13
- 2021-12-14
-
2021-12-22
Survey response — day 21, dose 3MedDRA: Blood bicarbonate increased, Blood glucose increased, Dizziness, Hypersomnia, Urine output decreased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Elevated bicarbonate, low urine output, hypersomnia, lightheadedness, elevated glucoseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Survey response — day 28, dose 3MedDRA: Discomfort, Ear discomfort — Feeling: GoodFree text: Inner ear and throat pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-01-04
Survey response — day 35, dose 3MedDRA: Autonomic nervous system imbalance, Dizziness, Erythromelalgia, Tonsillolith — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening dysautonomia, worsening lightheadedness, worsening erythromelalgia, tonsil stones (all of these conditions are ongoing or recurrent)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Survey response — day 42, dose 3MedDRA: Heavy menstrual bleeding, Menstruation delayed — Feeling: FairFree text: Menstrual period was one day late, heavier, lasted longer, and my typical hygiene products did not fit as comfortably as they normally doMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Survey response — 3 months, dose 3MedDRA: Back pain, Blood potassium decreased, Blood pressure inadequately controlled, Heart rate abnormal, Neck pain, Oedema — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Worsening back and neck pain, uncontrollable heart rate & blood pressure, edema, low potassiumMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-03
- 2022-12-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Moderna | |
| 2 | 2021-02-18 | Moderna | |
| 3 | 2021-11-30 | Moderna | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheadedness
Release 6 — day 42, dose 2
Symptoms: Dissociation/derealization
Healthcare visit (other): In office visit with psych and PCP
Release 9 — 6 months, dose 2
Symptoms: Autonomic dysfunction
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Groggy/brain fog, ear fullness, head & facial pressure, EXTREMELY red & splotchy/discolored hands & feet
Release 10 — day 21, dose 3
Symptoms: Elevated bicarbonate, low urine output, hypersomnia, lightheadedness, elevated glucose
Release 10 — day 28, dose 3
Symptoms: Inner ear and throat pressure
Release 10 — day 35, dose 3
Symptoms: Worsening dysautonomia, worsening lightheadedness, worsening erythromelalgia, tonsil stones (all of these conditions are ongoing or recurrent)
Release 10 — day 42, dose 3
Symptoms: Menstrual period was one day late, heavier, lasted longer, and my typical hygiene products did not fit as comfortably as they normally do
Release 11 — 3 months, dose 3
Symptoms: Worsening back and neck pain, uncontrollable heart rate & blood pressure, edema, low potassium
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Autonomic nervous system imbalance | ✓ | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Blood bicarbonate increased | · | · | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Blood potassium decreased | · | · | ✓ |
| SD | Blood pressure inadequately controlled | · | · | ✓ |
| SD | Derealisation | ✓ | ✓ | ✓ |
| SD | Discomfort | · | · | ✓ |
| SD | Dissociation | ✓ | ✓ | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Ear discomfort | · | · | ✓ |
| SD | Erythromelalgia | · | · | ✓ |
| SD | Heart rate abnormal | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Hypersomnia | · | · | ✓ |
| SD | Menstruation delayed | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Oedema | · | · | ✓ |
| SD | Tonsillolith | · | · | ✓ |
| SD | Urine output decreased | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Discomfort | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Ear discomfort | · | · | ✓ |
| SRO | Head discomfort | · | · | ✓ |
| SRO | Rash macular | · | · | ✓ |
| SRO | Skin discolouration | · | · | ✓ |
| SRO | Somnolence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release